Nateglinide for Diabetes

Browse eMedTV's wide range of articles related to nateglinide for diabetes including topics such as generic nateglinide, nateglinide dosing, and nateglinide side effects. Use the search box at the top-right corner of the page to find information about other health topics.

 Read About 
 
Description of Articles in Nateglinide for Diabetes

Nateglinide is often prescribed to lower blood sugar in people with type 2 diabetes. This eMedTV resource explains how the drug works to increase insulin production, lists possible side effects, offers tips on taking the medication, and more.

This portion of the eMedTV Web site lists both common and serious nateglinide side effects to be aware of, including dizziness, joint problems, and low blood sugar. This article also explains what to do should any of these side effects occur.

What is nateglinide used for? The medication treats type 2 diabetes by controlling blood sugar levels. This eMedTV article explains how it works to increase insulin production in the pancreas and also explains why the drug is not used in children.

As this eMedTV page explains, the starting dose of nateglinide is generally 120 mg, taken before each meal. However, the nateglinide dosing amount may be lower based on certain blood sugar tests. This page also offers some tips on taking the drug.

This eMedTV page describes the potential drug interactions with nateglinide that can occur when it is taken with other medicines, such as thyroid medications, beta blockers, and MAOIs. This page also lists the problems these interactions can cause.

This eMedTV page describes several precautions and warnings with nateglinide, such as the potential for allergic reactions, the risk of low blood sugar, and the danger of taking the drug when pregnant. This page also lists who should avoid the drug.

This eMedTV article explains that a patent currently prevents any generic nateglinide from being manufactured until 2009, when the patent expires. This page also offers a warning about companies claiming to sell a generic version of the drug.